Thiotepa-based conditioning for allogeneic stem cell transplantation (allo-HSCT) in acute lymphoblastic leukaemia (ALL) - a survey and matched-pair analysis from the ALWP of the EBMT

被引：0
|
作者：
Eder, S. [1 ,2 ]
Beohou, E. [1 ]
Labopin, M. [1 ]
Sanz, J. [3 ]
Finke, J. [4 ]
Arcese, W. [5 ]
Or, R. [6 ]
Bonifazi, F. [7 ]
Aljurf, M. [8 ]
Socie, G. [9 ]
Passweg, J. [10 ]
Giebel, S. [1 ,11 ,12 ]
Mohty, M. [1 ,2 ]
Nagler, A. [1 ,13 ,14 ]
机构：
[1] EBMT Off Paris, Paris, France
[2] Hop St Antoine, Serv Hematol Clin & Therapie Cellulaire, F-75571 Paris, France
[3] Hosp Univ & Politecn La Fe, Serv Hematol, Valencia, Spain
[4] Univ Med Ctr Freiburg, Hematol Oncol, Freiburg, Germany
[5] Univ Roma Tor Vergata, Dept Hematol & Transplant, Rome, Italy
[6] Hadassah Univ Hosp, Bone Marrow Transplantat, IL-91120 Jerusalem, Israel
[7] Univ Bologna, S Orsola M Malpighi Hosp, Inst Hematol & Med Oncol L&A Seragnoli, Bologna, Italy
[8] King Faisal Specialist Hosp & Res Ctr, Sect Adult Haematol BMT, Oncol, Riyadh 11211, Saudi Arabia
[9] Hosp St Louis, Dept Hematol BMT, Paris, France
[10] Univ Basel Hosp, Hematol, CH-4031 Basel, Switzerland
[11] Maria Sklodowska Curie Mem Canc Ctr, Gliwice, Poland
[12] Inst Oncol, Gliwice Branch, Gliwice, Poland
[13] Chaim Sheba Med Ctr, Div Hematol, IL-52621 Tel Hashomer, Israel
[14] Tel Aviv Univ, Tel Hashomer, Israel
来源：
BONE MARROW TRANSPLANTATION | 2016年 / 51卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O018
引用
收藏
页码：S11 / S12
页数：2
相关论文
共 50 条
  • [1] Thiotepa-Based Conditioning for Allogeneic Stem Cell Transplantation (allo-HSCT) in Acute Lymphoblastic Leukaemia (ALL) - a Survey from the Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT)
    Eder, Sandra
    Beohou, Eric
    Labopin, Myriam
    Sanz, Jaime
    Finke, Juergen
    Arcese, William
    Or, Reuven
    Bonifazi, Francesca
    Cortelezzi, Agostino
    Majolino, Ignazio
    Bacigalupo, Andrea
    Spyridonidis, Alexandros
    Alessandrino, Emilio Paolo
    Giebel, Sebastian
    Mohty, Mohamad
    Nagler, Arnon
    BLOOD, 2015, 126 (23)
  • [2] THIOTEPA-BASED CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) - A SURVEY FROM THE ALWP OF THE EBMT
    Eder, S.
    Labopin, M.
    Finke, J.
    Bunjes, D.
    Olivieri, A.
    Santarone, S.
    Rambaldi, A.
    Kanz, L.
    Messina, G.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S102 - S102
  • [3] Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT
    Eder, S.
    Labopin, M.
    Finke, J.
    Bunjes, D.
    Olivieri, A.
    Santarone, S.
    Rambaldi, A.
    Kanz, L.
    Messina, G.
    Mohty, M.
    Nagler, A.
    BONE MARROW TRANSPLANTATION, 2017, 52 (02) : 238 - 244
  • [4] Safety and efficacy of thiotepa-based conditioning for allogeneic transplantation in AML: a survey from the ALWP of the EBMT
    S Eder
    M Labopin
    J Finke
    D Bunjes
    A Olivieri
    S Santarone
    A Rambaldi
    L Kanz
    G Messina
    M Mohty
    A Nagler
    Bone Marrow Transplantation, 2017, 52 : 238 - 244
  • [5] Thiotepa-based versus total body irradiation/cyclophosphamide-based myeloablative conditioning prior to allo-HSCT for acute myeloid leukemia in first complete remission, an update: a retrospective matched-pair analysis from the ALWP of the EBMT
    Eder, S.
    Labopin, M.
    Arcese, W.
    Or, R.
    Majolino, I.
    Bacigalupo, A.
    de Rosa, G.
    Volin, L.
    Beelen, D.
    Veelken, H.
    Schaap, N.
    Kuball, J.
    Cornelissen, J.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2015, 50 : S13 - S14
  • [6] FLUDARABINE PLUS TREOSULFAN OR TBI AS A CONDITIONING THERAPY BEFORE ALLOGENEIC HSCT IN ACUTE LYMPHOBLASTIC LEUKEMIA. A MATCHED-PAIR ANALYSIS FROM THE ALWP OF THE EBMT
    Swoboda, Ryszard
    Labopin, Myriam
    Kroeger, Nicolaus
    Stelljes, Matthias
    Schroeder, Thomas
    Dreger, Peter
    Bug, Gesine
    McDonald, Andrew
    Ozcelik, Tulay
    Rovira, Montserrat
    Blau, Igor Wolfgang
    Kunadt, Desiree
    Socie, Gerard
    Rabitsch, Werner
    Eder, Matthias
    Rubio, Marie Therese
    Spyridonidis, Alexandros
    Savani, Bipin
    Peric, Zinaida
    Giebel, Sebastian
    Mohty, Mohamad
    Ciceri, Fabio
    BONE MARROW TRANSPLANTATION, 2024, 59 : 62 - 63
  • [7] Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
    Eder, Sandra
    Canaani, Jonathan
    Beohou, Eric
    Labopin, Myriam
    Sanz, Jaime
    Arcese, William
    Or, Reuven
    Finke, Juergen
    Cortelezzi, Agostino
    Beelen, Dietrich
    Passweg, Jakob
    Socie, Gerard
    Gurman, Gunhan
    Aljurf, Mahmoud
    Stelljes, Matthias
    Giebel, Sebastian
    Mohty, Mohamad
    Nagler, Arnon
    AMERICAN JOURNAL OF HEMATOLOGY, 2017, 92 (10) : 997 - 1003
  • [8] Treosulfan Based Conditioning Prior To Allogeneic Stem Cell Transplantation (HSCT) For Acute Myelogenous Leukemia (A L): A Retrospective Analysis From The ALWP Of The EBMT
    Nagler, Arnon
    Labopin, Myriam
    Shimoni, Avichai
    Beelen, Dietrich
    Kyrcz-Krzemien, Slawomira
    Schufer-Eckart, Kerstin
    Volin, Liisa
    Hallek, Michael
    Griskevicius, Laimonas
    Blau, Igor-Wolfgang
    Casper, Jochen
    Ciceri, Fabio
    Mohty, Mohamad
    BLOOD, 2013, 122 (21)
  • [9] TREOSULFAN BASED CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOGENOUS LEUKEMIA (AML): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF THE EBMT
    Nagler, A.
    Labopin, M.
    Shimoni, A.
    Beelen, D.
    Kyrcz-Krzemien, S.
    Schufer-Eckart, K.
    Volin, L.
    Hallek, M.
    Griskevicius, L.
    Blau, I. Wolfgang
    Casper, J.
    Ciceri, F.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S7 - S7
  • [10] THIOTEPA-BASED VS TBI-BASED MYELOABLATIVE CONDITIONING PRIOR TO ALLOGENEIC STEM CELL TRANSPLANTATION (HSCT) FOR ACUTE MYELOID LEUKEMIA (AML) IN FIRST COMPLETE REMISSION (CR1): A RETROSPECTIVE ANALYSIS FROM THE ALWP OF THE EBMT
    Eder, S.
    Labopin, M.
    Arcese, W.
    Or, R.
    Majolino, I.
    Bacigalupo, A.
    de Rosa, G.
    Volin, L.
    Beelen, D.
    Veelken, H.
    Schaap, N. P.
    Kuball, J.
    Cornelissen, J.
    Nagler, A.
    Mohty, M.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S106 - S106
12345